title: Eruptive disseminated porokeratosis associated with corticosteroid-induced immunosuppression.
abstract: Eruptive disseminated porokeratosis (EDP) is a disease that presents clinically with sudden onset of erythematous papules and plaques, with a ridge-like border histologically represented by a cornoid lamella. We report a case of EDP occurring in a 39-year-old woman 3 days after completion of a 2-week course of oral corticosteroid therapy for an acute asthma exacerbation. The patient was treated with emollients and sun protection. Unlike the more chronic disseminated superficial (actinic) porokeratosis, EDP secondary to immunosuppression from corticosteroid therapy has very rarely been reported in the dermatological literature.
authors: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.
authors: R
authors: R
authors: Bednarek
authors: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.
authors: N
authors: N
authors: Ezra
authors: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.
authors: Y
authors: Y
authors: Toubin
authors: Department of Pathology, Division of Dermatopathology, Indiana University School of Medicine, Indianapolis, IN, USA.
authors: K
authors: K
authors: Linos
authors: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.
authors: N
authors: N
authors: Mousdicas
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017499:Porokeratosis / Q000139:chemically induced*; D011241:Prednisone / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D011241:Prednisone